Ascelia Pharma AB banner

Ascelia Pharma AB
STO:ACE

Watchlist Manager
Ascelia Pharma AB Logo
Ascelia Pharma AB
STO:ACE
Watchlist
Price: 2.96 SEK -1.33% Market Closed
Market Cap: kr375.5m

Wall Street
Price Targets

ACE Price Targets Summary
Ascelia Pharma AB

Wall Street analysts forecast ACE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACE is 8.16 SEK with a low forecast of 6.57 SEK and a high forecast of 9.98 SEK.

Lowest
Price Target
6.57 SEK
122% Upside
Average
Price Target
8.16 SEK
176% Upside
Highest
Price Target
9.98 SEK
237% Upside
Ascelia Pharma AB Competitors:
Price Targets
ELAN
Elanco Animal Health Inc
30% Upside
FBIZ
First Business Financial Services Inc
29% Upside
EOLS
Evolus Inc
273% Upside
NNOX
Nano-X Imaging Ltd
242% Upside
INBK
First Internet Bancorp
32% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
18%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
18%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-44%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-44%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACE's stock price target?
Price Target
8.16 SEK

According to Wall Street analysts, the average 1-year price target for ACE is 8.16 SEK with a low forecast of 6.57 SEK and a high forecast of 9.98 SEK.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett